Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Hong Kong ETF

22.87
+0.32001.42%
Post-market: 22.870.00000.00%19:30 EDT
Volume:3.16M
Turnover:72.26M
Market Cap:1.22B
PE:15.65
High:22.90
Open:22.74
Low:22.74
Close:22.55
52wk High:24.66
52wk Low:20.60
Shares:53.55M
Float Shares:53.55M
Volume Ratio:1.23
T/O Rate:5.90%
Dividend:1.04
Dividend Rate:4.53%
EPS(TTM):1.46
EPS(LYR):5.66
ROE:34.64%
ROA:2.14%
PB:1.57
PE(LYR):4.04

Loading ...

Morgan Stanley Maintains Overweight on Swire Properties, Cuts Target Price to HK$28

Deep News
·
Aug 23

Morgan Stanley Trims China Resources Beer Target to HK$30, Maintains Overweight Stance

Deep News
·
Aug 23

UBS Raises HKEX Price Target to HK$450, Maintains Neutral Stance

Deep News
·
Aug 23

UBS Raises ND Paper Target Price to HK$11.82, Keeps 'Buy' Rating

Deep News
·
Aug 23

Morgan Stanley Raises BOC Hong Kong Target Price to HK$44.2, Maintains Underweight Rating

Deep News
·
Aug 23

UBS trims AIA target price to HK$102, maintaining "Buy" rating

Deep News
·
Aug 23

Morgan Stanley Lifts Pharmaron Target Price to HK$35.60, Maintains Overweight Rating

Deep News
·
Aug 23

AAC TECH Rating Maintained as Price Target Lifted to HK$52

Deep News
·
Aug 23

Goldman Sachs Lifts NetEase Price Target to HK$263, Maintains Buy Rating

Deep News
·
Aug 23

BofA Securities Lifts CSPC Pharma Target Price to HK$8.6 While Maintaining Underperform Rating

Deep News
·
Aug 23

Morgan Stanley Trims HYSAN DEV Target Price to HK$19, Keeps "Market Perform" Rating

Deep News
·
Aug 23

Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call

Deep News
·
Aug 23

BofA Securities Adjusts Fuyao Glass Price Target While Retaining Buy Stance

Deep News
·
Aug 23

Citi Trims CHINA OVS PPT Price Target to HK$4.5, Keeps 'Buy' Rating

Deep News
·
Aug 23

CITIC Securities Initiates Coverage on SHOUGANG LANZA with Buy Rating and HK$44 Target Price

Deep News
·
Aug 23

JPMorgan Raises J&T Express Price Target to HK$14, Retains Overweight Stance

Deep News
·
Aug 23

Daiwa Raises KEYMED BIO-B Price Target to HK$110, Reaffirming Buy Call

Deep News
·
Aug 23

BofA Securities Cuts Huaneng Power's Price Target to HK$4.9, Reiterates Underperform Rating

Deep News
·
Aug 23

UBS Lifts CSPC Pharma Price Target to HK$11.80, Reiterates Buy Rating

Deep News
·
Aug 23

Goldman Sachs Downgrades Hysan Development to Sell, Slashes Target Price to HK$16

Deep News
·
Aug 23